Cleveland BioLabs, Inc. (CBLI)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Cleveland BioLabs, Inc. (CBLI)
10 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CBLI
- Alan Brochstein(7)
- The Wall Street Transcript(1)
- H.S. Ayoub(1)
- Zacks.com (1)
Most popular authors
(tracked in watchlists)
- Alan Brochstein(222)
- Zacks.com (139)
- The Wall Street Transcript(52)
- H.S. Ayoub(2)
Most commented on authors
- Alan Brochstein(15)
- The Wall Street Transcript(0)
- H.S. Ayoub(0)
- Zacks.com (0)
- Cleveland BioLabs: Robust Pipeline, Attractive Valuation
- An Interview With Cleveland BioLabs CEO Michael Fonstein
- Cancer Stocks: Tracking the Market
- Cancer Stocks: The Bleeding Slows
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Three Drugs Have Potential to Treat Polonium-210 Radiation
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »